Literature DB >> 20213928

[Cerebral vasculitis associated with gemcitabine].

P Schmorl1, A Heer-Sonderhoff, R Vosshenrich, S Conrad.   

Abstract

Neoadjuvant chemotherapy consisting of cisplatin and gemcitabine was given to a 50-year-old woman suffering from transitional cell carcinoma of the bladder. Whereas the first cycle was administered without major side effects, the patient experienced a generalized tonic-clonic seizure and a prolonged cognitive deficit with the second cycle. Magnetic resonance imaging of the brain was consistent with cerebral vasculitis. The short interval between the application of gemcitabine and the neurological deterioration suggests a causal relationship. Although recent reports have linked this drug with leukoencephalopathy and vasculitis in various localizations, this is the first case of cerebral vasculitis associated with gemcitabine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213928     DOI: 10.1007/s00120-009-2203-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

1.  Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.

Authors:  M J Banach; G A Williams
Journal:  Arch Ophthalmol       Date:  2000-05

Review 2.  Clinical evaluation of diagnostic tests.

Authors:  Susan Weinstein; Nancy A Obuchowski; Michael L Lieber
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

3.  Chemotherapy induced reversible posterior leukoencephalopathy syndrome.

Authors:  Roisin M Connolly; Colin P Doherty; Peter Beddy; Ken O'Byrne
Journal:  Lung Cancer       Date:  2007-02-20       Impact factor: 5.705

Review 4.  Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer.

Authors:  H von der Maase
Journal:  Eur J Cancer       Date:  2000-07       Impact factor: 9.162

5.  Vasculitis due to gemcitabine.

Authors:  A M C J Voorburg; F T van Beek; P H Th J Slee; C A Seldenrijk; F M N H Schramel
Journal:  Lung Cancer       Date:  2002-05       Impact factor: 5.705

6.  Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.

Authors:  L Vénat-Bouvet; K Ly; J C Szelag; J Martin; J L Labourey; D Genet; N Tubiana-Mathieu
Journal:  Anticancer Drugs       Date:  2003-11       Impact factor: 2.248

7.  Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer.

Authors:  John P Geisler; Daniel F Schraith; Kelly J Manahan; Joel I Sorosky
Journal:  Gynecol Oncol       Date:  2004-02       Impact factor: 5.482

8.  Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.

Authors:  M Birlik; S Akar; E Tuzel; F Onen; E Ozer; M Manisali; Z Kirkali; N Akkoc
Journal:  J Cancer Res Clin Oncol       Date:  2004-01-27       Impact factor: 4.553

9.  Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.

Authors:  Anita Rajasekhar; Thomas J George
Journal:  Oncologist       Date:  2007-11
  9 in total
  3 in total

1.  Clinical Reasoning: A 77-year-old man presenting with episodic expressive aphasia.

Authors:  Alice Shanklin; Andrew Cox; Hamdy M A Ahmed; Alicia Lieberman; Ania Busza
Journal:  Neurology       Date:  2018-05-15       Impact factor: 9.910

2.  Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect.

Authors:  Toby A Eyre; Sarah Gooding; Ishita Patel; Niall Moore; Chris Hatton; Graham P Collins
Journal:  Int J Hematol       Date:  2014-03-02       Impact factor: 2.490

3.  Langerhans Cell Histiocytosis Causing Central Nervous System Vasculitis Leading to Stroke in a Two-year-old Boy: A Case Report.

Authors:  Nathan T Froelich; Elias Rizk
Journal:  Cureus       Date:  2019-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.